Coefficient Bioacquired
Coefficient Bio develops an AI platform designed to automate and optimize the pharmaceutical research and development lifecycle.
Funding
Every round, secondary, debt facility or acquisition involving Coefficient Bio that AI Lounge tracks, newest first. Latest: Acquisition on Apr 3, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in